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Serum and plasma dopamine-beta-hydroxylase
(DBH, E. C. 1. 14. 17. 1.) activity has been
measured by several investigators in order to assess
its value for the diagnosis of neural crest tumours.
In children with neuroblastoma both elevated and
normal values have been reported (Goldstein et al.,
1972; Brewster et al., 1979). Recently Eldeeb et al.
(1983) published evidence indicating that the DBH
activity is related neither to the disease state nor to
the urinary catecholamine output. These authors
concluded that this enzyme has no diagnostic value
and is poorly correlated to tumour growth. As
shown below our results support the conclusions of
Eldeeb et al. (1983) and suggest that the procedure
used to determine serum DBH activities might be
inadequate. For DBH assays a convenient spectro-
photometric method, initially described by Nagatsu
& Udenfriend (1972), has been widely used. The
inability to detect low DBH activity levels in
laboratory animals or in humans with genetically
low DBH activity demonstrates, however, that this
method lacks sensitivity. In addition strong inter-
individual variability was noticed (Weinshilboum,
1978).
The original description of Nagatsu and
Udenfriend's assay prescribes incubation of 2-50pl
human serum or plasma diluted with water to
400p1 in a standard incubation mixture containing
sodium acetate buffer (1moll-', pH, 5.0) 200p1;
sodium fumarate (0.2moll-1) 50pl; pargyline
(20mmoll-') 50p; catalase (lmgml-') 50ul
(= 1500U); tyramine-HCl (0.4mol -') 50I1 and N-
ethylmaleimide (0.2molI1) 150p1. A sample of a
boiled enzyme preparation is run as a blank. After
incubation at 37°C for 60min in a water bath with
continuous shaking, the reaction is stopped by
adding 0.2ml of 3 M trichloracetic acid. The
mixture is centrifugated at 2000rpm for 10min.
The supernatant is then transferred to a small
column of Dowex 50 (H+, mesh 200-400) - packed
volume 0.2ml - which has been prepared in a
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disposable Pasteur pipette. The tube and the
precipate are washed with 1ml of distilled water
which is also transferred to the column. After
washing the column twice with 2ml of distilled
water the adsorbed amines are eluted with 1 ml of
4M NH40H. In the elute tyramine derived
octopamine is converted to p-hydroxy-benzaldehyde
by adding 0.1 ml of NaIO4 solution (20g1-1).
Excess perjodate is then reduced by 0.1 ml Na2S2O0
(100 g -1) and the absorbance is measured against
water at 330nm in a semimicrocuvet with a 1 cm
light path (Zeiss PQM TI).
For the repeated determinations of the same
material (intra-batch) a coefficient of variation
(CV) varying between 1.8% (Nagatsu &
Udenfriend, 1972) and 3% (Eldeeb et al., 1983)
has been indicated. Since in our hands the CV was
considerably higher we tested the method with
standard concentrations of octopamine. Increasing
amounts of octopamine were transferred to the
columns and the recovery after elution with 1.Oml
NH40H (=No. 1 eluate) was 98.0+4.2% for
columns packed with Dowex 5OW, 8X (mesh 200-
400) (n=30) and 79.1+8.2% for columns packed
with Dowex 5OW, 12X (mesh 200-400) (same n).
Following a second wash with 1.0ml NH40H
(=No. 2 eluate) no further recovery was obtained
with the Dowex 50WW, 8X, but an additional
recovery of 20% was obtained with Dowex
50W,12X columns. It was also noticed that up to
60 nmol octopamine the recovery from the columns
was nearly linear to the standard curve (octopamine
in 1.0ml of 4M ammonium carried only through
the oxidation procedure). When higher concen-
trations of octopamine were loaded on the columns
the recovery in the first eluate decreased but
increased in the second eluate.
For intra-batch analysis we used heparinized
plasma and tested 20-30 columns with lOul of
plasma per column. The results of these assays are
summarized in Table I: First, the recovery of the
activity from the Dowex 50W,8X column in the
first eluate (El, first ml of ammonia to wash the
columns) is significantly lower for plasma samples
than for pure octopamine solutions: Second, in all
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Table I Intra-batch analysis of DBH in 4 different plasma samples
El E2 T
N x+s.d. Range CV % of T i+s.d. Range CV % of T x+s.d. Range CV
Dowex 50W, 8X
Plasma 1 25 51.3+3.8 42-61 7.5 79.4 13.3+3.0 7-21 23.0 20.6 64.6+3.1 57-70 4.8
Plasma 2 20 26.2+4.9 17-34 19.0 85.4 4.5+2.1 0-8 48.0 14.6 30.9+4.5 22-38 14.0
Plasma 3 30 20.5+3.9 16-27 19.2 76.8 6.3+1.5 2-9 24.8 23.2 27.5+2.8 23-34 10.4
Dowex 50W, 12X
Plasma 4 30 55.7+8.0 40-69 14.5 70.6 19.6+4.2 12-29 21.6 29.4 78.8 +8.2 64-94 10.4
Values are expressed in international units =Mmol octopamine formed per min and per 1 plasma at 370C. El denotes
eluate No. 1 (=first ml of 4M ammonia to wash the column) and E2 denotes eluate No. 2 (=second ml of 4M
ammonia). T=total activity recoverable from the column. CV=coefficient of variation.
experiments the No. 1 eluate recovers only 70-85%
of the overall activity (T): Third, there is a wide
range of results obtained with the same plasma
batch and fourth, the CV characterizing the repro-
ducibility of activity determinations in the first
eluate varies between 7.5 and 19%. This range can
be decreased to 4.8-14% by a second washing.
For day to day subsequent reproducibility (inter-
batch) a similar variability was observed.
Despite these methodological implications we
studied plasma DBH activity in 29 children (age
0.5-15 years) without neurogenic tumour and in 20
children (age 0.1-8 years) with proven neuro-
blastoma.
As described by others an age dependent increase
of the values was found. There was no correlation,
however, between activity levels and the diagnosis
of neuroblastoma or the state of disease. As noticed
by Eldeeb et al. (1983), DBH activity
determinations are therefore not helpful for the
diagnosis of neuroblastoma. It is questionable,
furthermore, whether the spectrophotometric assay
widely used is sensitive enough and since other
procedures do not seem to provide more reliable
information (Weinshilboum, 1979) conclusions
based on the measurements of DBH activities
should be interpreted accordingly.
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